Marinus Pharmaceuticals Inc (STU:61Y)
€ 0.292 0.076 (35.19%) Market Cap: 19.67 Mil Enterprise Value: 32.91 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 36/100

Marinus Pharmaceuticals, Inc. - Special Call Transcript

Jun 30, 2020 / 12:00PM GMT
Release Date Price: €8.72 (-5.22%)
Unidentified Participant

Good morning and welcome to the Marinus Pharmaceuticals R&D Day Webinar. As a reminder, today's presentation is being recorded and replay will be made available on the Marinus website at the conclusion of the event. Today we'll be conducting Q&A sessions throughout the meeting. (Operator Instructions).

At this time, I'd like to turn the call over to your host, Sasha Damouni, Vice President of Investor Relations and Corporate Communications at Marinus Pharmaceuticals.

Please go ahead, Sasha.

Sasha Damouni Ellis
Marinus Pharmaceuticals, Inc. - VP of IR & Corporate Communication

Thanks, [Sara]. Good morning, everybody.

If we could go to the next slide. On behalf of Marinus, I would like to say hello and welcome to everyone to our R&D Day. My name is Sasha Damouni, and I am VP of Investor Relations and Corporate Comms. I will first begin with our forward-looking statement disclosure. Next, I would like to introduce our speakers for the day.

If you turn the slide. As you can see, we have 4

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot